• Accueil >
  • Publications >
  • Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

1 déc. 2019Clinical Colorectal Cancer

DOI : 10.1016/j.clcc.2019.08.004

Auteurs

Lorenzo Fornaro, Francesco Leone, Angélique Vienot, Andrea Casadei-Gardini, Caterina Vivaldi, Astrid Lièvre, Pasquale Lombardi, Emmanuele De Luca, Dewi Vernerey, Elisa Sperti, Gianna Musettini, Maria Antonietta Satolli, Julien Edeline, Rosella Spadi, Cindy Neuzillet, Alfredo Falcone, Giulia Pasquini, Mario Clerico, Alessandro Passardi, Paola Buscaglia, Aurélia Meurisse, Massimo Aglietta, Clémence Brac, Enrico Vasile, Francesco Montagnani